Joseph G. Oberlander serves as a Clinical Supply Chain Specialist at Syner-G BioPharma Group, where he plays a pivotal role in the execution of comprehensive global strategies for the investigational drug supply chain. His expertise spans various critical areas, including neuronal cell biology and synaptic...
Joseph G. Oberlander serves as a Clinical Supply Chain Specialist at Syner-G BioPharma Group, where he plays a pivotal role in the execution of comprehensive global strategies for the investigational drug supply chain. His expertise spans various critical areas, including neuronal cell biology and synaptic physiology, which underpin his contributions to the development of innovative therapies targeting central nervous system (CNS) and endocrinology diseases. In his current position, Joseph is responsible for overseeing supply chain operations for early- and mid-phase clinical trial programs, ensuring that all aspects of the supply chain align with Good Manufacturing Practice (GMP) standards.
A key aspect of Joseph's role involves the meticulous management of inventory and expiry monitoring, which he accomplishes through the collaboration with CMC experts and contract development and manufacturing organizations (CDMOs). His strategic planning skills enable him to effectively coordinate stability programs for both drug product (DP) and drug substance (DS), ensuring that investigational products are maintained under optimal conditions throughout their lifecycle. Joseph's extensive background in clinical trial analysis and supply chain management allows him to navigate complex project landscapes, fostering cross-functional team leadership to drive successful outcomes.
In addition to his supply chain responsibilities, Joseph's research experience, which includes evaluating medical devices and pharmacological interventions, enhances his ability to contribute to the development of robust clinical programs. His proficiency in techniques such as Western blotting, immunohistochemistry, and high-performance liquid chromatography (HPLC) further solidifies his role as a valuable asset to the Syner-G BioPharma Group, where he is committed to advancing the frontiers of pharmaceutical development through innovative supply chain solutions.
